Labshake search
Citations for R&D Systems :
1 - 50 of 266 citations for PD L2 Cynomolgus HEK 293 Fc since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2024Quote: ... samples were treated with recombinant human PD-1 Fc protein (1086-PD-050, R&D System) at 4 °C overnight ...
-
bioRxiv - Immunology 2020Quote: ... The expression of PD-L1 and IL-6 from bronchoalveolar lavages was quantitated following the protocols of ELISA kits: Human IL-6 Quantikine ELISA Kit and Human/Cynomolgus Monkey B7-H1/PD-L1 Quantikine ELISA Kit from R&D Systems.
-
bioRxiv - Cancer Biology 2022Quote: ... recombinant mouse PD-1-Fc chimeric protein (R&D Systems) or human IgG1 control (R&D Systems) ...
-
bioRxiv - Cancer Biology 2023Quote: ... or mouse rPD-1-Fc (R&D Systems #1021-PD-100) for 0 ...
-
bioRxiv - Immunology 2023Quote: ... recombinant human PD-L1 human IgG1 Fc chimera protein (R&D Systems), or mouse IgG1 isotype antibodies (R&D Systems ...
-
bioRxiv - Immunology 2021Quote: ... wells were coated with 30 μg/mL PD-L1-Fc chimera protein (R&D Systems) or 6 μg/mL anti-ICOS (clone C398.4A ...
-
bioRxiv - Synthetic Biology 2023Quote: ... PD-1-DNR interaction with PD-L1 was assessed by staining with 1 μg Recombinant Mouse PD-L1/B7-H1 Fc Chimera Protein (R&D Systems, 1019-B7-100), followed by anti-hFc antibody.
-
bioRxiv - Immunology 2024Quote: ... following reagents were used in flow cytometry: recombinant human PD-L1 Fc chimera Biotin protein (R&D Systems); APC Streptavidin (Tonbo Biosciences) ...
-
bioRxiv - Cancer Biology 2020Quote: ... with C-terminal 6xHis tag produced in HEK293 cells and human recombinant PD-L1-Fc chimera protein produced in mouse NS0 cells were obtained from R&D Systems, Minneapolis ...
-
bioRxiv - Immunology 2021Quote: ... and either 7µg of Recombinant PD-L1/B7-H1 Fc Chimera Protein (mouse: R&D System 1019-B7; human: R&D System 156-B7) (indicated as anti-CD3/28-PDL1-beads ...
-
bioRxiv - Immunology 2021Quote: ... and either 7µg of Recombinant PD-L1/B7-H1 Fc Chimera Protein (mouse: R&D System 1019-B7; human: R&D System 156-B7) (indicated as anti-CD3/28-PDL1-beads ...
-
bioRxiv - Cancer Biology 2023Quote: ... cells were treated with 1 μg/mL of either human rPD-1 (hrPD-1-Fc; R&D Systems #1086-PD-050; Minneapolis, MN, USA) or mouse rPD-1-Fc (R&D Systems #1021-PD-100 ...
-
bioRxiv - Immunology 2023Quote: Serum and recombinant PD-1 was quantified by human PD-1 Quantikine ELISA and human PD-1 DuoSet ELISA (R&D Systems, Minneapolis, MN), following manufacturer’s protocol ...
-
bioRxiv - Immunology 2022Quote: ... PD-1 Ig (R&D Systems), CTLA-4 Ig (Abatacept ...
-
bioRxiv - Bioengineering 2021Quote: ... To create multiple loading densities a series of concentrations of PD-1 (R&D systems, #8986-PD) or PD-L1 (R&D systems ...
-
bioRxiv - Bioengineering 2023Quote: Recombinant B7H3-Fc and Her2-Fc (R&D systems) were used to detection B7H3 and Her2 surface CAR ...
-
bioRxiv - Bioengineering 2021Quote: ... or PD-L1 (R&D systems, #156-B7) were applied to the sensors using a spotter (Scienion ...
-
bioRxiv - Cancer Biology 2022Quote: ... and PD-L1/B7-H1 (R&D Systems, AF1019-SP ...
-
bioRxiv - Immunology 2023Quote: ... VEGF (5ng/mL, R&D Systems, 293-VE), IL-6 (10ng/mL ...
-
bioRxiv - Immunology 2021Quote: ... Goat PD-L1 polyclonal antibody (#AF156, R&D Systems) was firstly conjugated with gold NPs using a gold conjugation kit (#ab201808 ...
-
Neutralizing PD-L1 and PD-L2 Enhances the Efficacy of Immune Checkpoint Inhibitors in Ovarian CancerbioRxiv - Cancer Biology 2020Quote: ... αHuman PD-L1 1:500 (#AF154, R&D systems,
-
bioRxiv - Physiology 2020Quote: ... PD-1 blocking antibody (R&D Systems/Techne, #AF1086) was included at the 10 µg/ml ...
-
bioRxiv - Cancer Biology 2020Quote: N-deglycosylation of recombinant PD-L1 (R&D Systems) was performed using PNGase F (New England Biolabs ...
-
bioRxiv - Bioengineering 2022Quote: ... 10 ng/mL VEGF (R&D Systems, 293-VE), 20 ng/mL EGF (PeproTech ...
-
bioRxiv - Immunology 2023Quote: ... 50 ng/ml VEGF (R&D Systems, 293-VE) and 2 μM CHIR99021 (Tocris ...
-
bioRxiv - Neuroscience 2022Quote: ... TrkB Fc chimera (acts via receptor sequestration)(TrkB Fc) (R&D Systems), was applied to SN cultures 1 h prior to fixation ...
-
bioRxiv - Neuroscience 2019Quote: Mouse EphrinB3-Fc fragments and human Fc were purchased by R&D Systems. The soluble forms of EphrinB3-Fc ...
-
bioRxiv - Bioengineering 2023Quote: ... cells were incubated with CD22-Fc or BCMA-Fc protein (R&D Systems) in PBS for 30 min on ice ...
-
bioRxiv - Biochemistry 2021Quote: ... recombinant glycoproteins (R&D Systems 1658-PD and 3345-PS) were digested overnight with mucinase SmEnhancin (38 ...
-
bioRxiv - Developmental Biology 2019Quote: ... 100ug/mL of VEGF (293-VE-010, R&D systems) was added to the F-12 media for 16-hour incubation or PBS for control ...
-
bioRxiv - Microbiology 2021Quote: ... 50 ng/mL VEGF (293-VE-500, R&D Systems), 2 μM CHIR99021 (4423 ...
-
bioRxiv - Cancer Biology 2020Quote: ... 10 ng/ml VEGF (R&D systems: 293-VE-010) or 10 μg/ml SERPINE1 (R&D systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... 10 ng/ml VEGF (R&D systems: 293-VE-010) or 10 μg/ml SERPINE1 (R&D systems ...
-
bioRxiv - Neuroscience 2022Quote: ... A subset of slices were infected with only AAV9.hsyn.GFP and at DIV6 were treated with human Sema4D-Fc ectodomain/human Fc fusion protein (Sema4D-Fc; R&D Systems, #7470-S4) or Fc control protein (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... rmICAM1-Fc (R&D systems).
-
bioRxiv - Immunology 2023Quote: ... DLL1-Fc (R&D Systems), or DLL4-Fc (Sino Biological ...
-
bioRxiv - Cancer Biology 2020Quote: ... anti-PD-L1 PE conjugated (R&D Systems cat no: FAB1561P), anti-PD-L1 (Cell Signaling ...
-
bioRxiv - Immunology 2022Quote: ... Recombinant human PD-L1 protein (R&D Systems, Cat# 156-B7) was used to make the standard curve ranging from 0.3125 to 10 ng/ml.
-
bioRxiv - Biochemistry 2023Quote: Aliquots containing 10 µg of podocalyxin (R&D Systems, 1658-PD) recombinantly expressed in NS0 cells were reconstituted at a concentration of 1 µg/µL in 50 mM AmBic and subjected to different mucinase treatments ...
-
bioRxiv - Cell Biology 2020Quote: ... Recombinant mouse ICAM-1-Fc and VCAM-1-Fc were purchased from R&D Systems. Antibodies for flow cytometery were from BioLegend ...
-
bioRxiv - Genomics 2020Quote: ... and 5ng/ml human VEGF (R&D Systems Cat#. 293-VE). The 2-day-old EBs were dissociated and 6×104 cells were seeded onto individual wells of a 24-well plate coated with 0.1% gelatin in StemPro-34 medium (Gibco #10639011) ...
-
bioRxiv - Bioengineering 2023Quote: ... vascular endothelial growth factor (VEGF) (R&D Systems, #293-FB/CF), epidermal growth factor (EGF ...
-
bioRxiv - Neuroscience 2022Quote: ... 5 μg/ml of TGF-β RII Fc chimera (TGF-β RII Fc) (R&D Systems), was applied to SN cultures 1 h prior to fixation to inhibit TGF-β signaling ...
-
bioRxiv - Developmental Biology 2022Quote: ... Fgfr2iiib-Fc (human, R&D Systems) and Phospho-p44/42 MAPK (rabbit ...
-
bioRxiv - Cancer Biology 2019Quote: ... or ULBP4-Fc (R&D Systems) coated onto microtiter plates ...
-
bioRxiv - Immunology 2020Quote: ... mouse ICAM1-Fc (R&D systems), FxCycle Violet Stain ...
-
bioRxiv - Cancer Biology 2023Quote: ... EphrinB1-Fc (R&D systems, USA) and control Fc fragment (R&D Systems ...
-
bioRxiv - Cancer Biology 2019Quote: ... mouse PD-L1 (R&D systems, AF1019, 1:500, Minneapolis, MN, USA), p-RB (Cell Signaling Technology ...
-
bioRxiv - Bioengineering 2023Quote: ... and VEGF 165 (293-VE) were all purchased from R&D Systems Inc ...
-
bioRxiv - Molecular Biology 2023Quote: ... and 5 ng/ml human VEGF (R&D Systems Cat#. 293-VE). The 2-day-old EBs were dissociated and 6 × 104 cells were seeded onto individual wells of a 24-well plate coated with 0.1% gelatine in EC Induction Medium consisting of StemPro-34 medium (Gibco #10639011) ...